Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/27/1996 | US5549906 Nicotine lozenge and therapeutic method for smoking cessation |
08/27/1996 | US5549901 Antimicrobial oil-in-water emulsions |
08/27/1996 | US5549888 Acidic mixtures containing salicyclic, retinoic, azelaic, lactic, glycolic or pyruvic acids, water soluble glycol ethers and nonionic surfactants |
08/27/1996 | US5549886 Photostable filtering cosmetic composition |
08/27/1996 | US5549675 Method for implanting tissue in a host |
08/27/1996 | CA2059377C Manufacture of water-swellable hydrophilic articles and drug delivery devices |
08/27/1996 | CA2001673C Pharmaceutical composition containing piroxicam |
08/27/1996 | CA1338554C Combination of tobramycin and steroids for topical ophthalmic use |
08/27/1996 | CA1338553C Pharmaceutical granulate containing cellulose product |
08/27/1996 | CA1338552C Use of asymmetric membranes in delivery devices |
08/23/1996 | CA2143136A1 Rub on topical anesthetic |
08/22/1996 | WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA |
08/22/1996 | WO1996025665A1 Three-dimensional colorimetric assay assemblies |
08/22/1996 | WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof |
08/22/1996 | WO1996025491A2 Inhibition of proliferation of vascular smooth muscle cell |
08/22/1996 | WO1996025409A1 Cosmetic or pharmaceutical compositions containing an ozonide-enriched natural vegetable oil, and uses thereof |
08/22/1996 | WO1996025392A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
08/22/1996 | WO1996025194A1 Medication and apparatus and method of applying medication |
08/22/1996 | WO1996025176A1 Therapeutic inhibitor of vascular smooth muscle cells |
08/22/1996 | WO1996025162A1 Means for treating onychomycosis |
08/22/1996 | WO1996025154A1 Transdermal formulation |
08/22/1996 | WO1996025153A1 Site-specific adhesion within the gi tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
08/22/1996 | WO1996025152A1 Process of preparing therapeutic compositions containing nanoparticles |
08/22/1996 | WO1996025151A1 Solid active agent preparations |
08/22/1996 | WO1996025150A1 Redispersible nanoparticulate film matrices with protective overcoats |
08/22/1996 | WO1996025149A1 Solid active agent preparations containing hydroxypropyl cellulose |
08/22/1996 | WO1996025148A1 A time-release delivery matrix composition and corresponding controlled-release compositions |
08/22/1996 | WO1996025147A1 Liposome composition and method for administering liposome-loadable drugs |
08/22/1996 | WO1996025146A1 Gram negative bacterial infection vaccine |
08/22/1996 | WO1996025145A1 Bio-erodible ophthalmic shield |
08/22/1996 | WO1996025042A1 Transdermal formulation |
08/22/1996 | DE19549330A1 Use of fluoro-uracil to treat nail fungus |
08/22/1996 | DE19506885A1 Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneolderivate, processes for their preparation and their pharmaceutical use |
08/22/1996 | DE19504832A1 Feste Wirkstoff-Zubereitungen Fixed drug preparations |
08/22/1996 | CA2213211A1 New borneol derivatives, process for their production, and their pharmaceutical use |
08/22/1996 | CA2212874A1 Transdermal formulation |
08/22/1996 | CA2211972A1 Three-dimensional colorimetric assay assemblies |
08/22/1996 | CA2211671A1 Solid active ingredient compositions containing hydroxypropylcellulose |
08/22/1996 | CA2211162A1 Nucleic acid-containing composition, preparation and use thereof |
08/22/1996 | CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta |
08/21/1996 | EP0727491A1 Enzymatic synthesis of soluble phosphatides from phospholipids |
08/21/1996 | EP0727222A1 Method of producing semi-solid preparations containing microparticulate substances |
08/21/1996 | EP0727221A2 Composition of ionizing solvent |
08/21/1996 | EP0727219A2 Medical gas mixture |
08/21/1996 | EP0727209A2 Transdermal formulation of a compound having muscarinic activity |
08/21/1996 | EP0727208A1 Transdermal formulation of a compound having muscarinic activity |
08/21/1996 | EP0727205A2 Thermoplastic coating and binder agent for pharmaceutical forms |
08/21/1996 | EP0726920A1 High molecular weight polyesterpolycarbonates and the use thereof for the preparation of bioerosible matrices |
08/21/1996 | EP0726910A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
08/21/1996 | EP0726779A1 Methods of stimulating phagocytosis |
08/21/1996 | EP0726777A1 Prokaryotic expression of mhc proteins |
08/21/1996 | EP0726776A1 Inhibition of hiv mucosal infection |
08/21/1996 | EP0726771A1 Desferrioxamine oral delivery system |
08/21/1996 | EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation |
08/21/1996 | EP0726766A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
08/21/1996 | EP0726765A1 Apparatus and method for preparing solid forms with controlled release of the active ingredient |
08/21/1996 | EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations |
08/21/1996 | EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
08/21/1996 | EP0726762A1 Charged liposome preparation |
08/21/1996 | EP0726761A1 Microparticular pharmaceutical compositions in micellar form |
08/21/1996 | EP0726760A1 Self-emulsible formulation forming an oil-in-water emulsion |
08/21/1996 | EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
08/21/1996 | EP0693923A4 Method for making a bioerodible material for the substained release of a medicament and the material made from the method |
08/21/1996 | EP0660723B1 Vp6 encapsulated drug delivery |
08/21/1996 | EP0589893B1 Use of a bacteriocin antimicrobial agent for the manufacture of a medicament for the treatment of gastric disorders associated with Helicobacter pylori. |
08/21/1996 | EP0588947B1 Long-term delivery device including hydrophobic loading dose |
08/21/1996 | EP0517820B1 Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity |
08/21/1996 | EP0512002B1 Cell-specific enzyme-conjugates for the release of toxic cyanide from cyanogenic prodrugs at target cells |
08/21/1996 | EP0478727B1 Process for the preparation of aqueous liposome suspensions containing active substances |
08/21/1996 | CN1129402A Method and apparatus for sealing implantable membrane encapsulation devices |
08/21/1996 | CN1129401A Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
08/21/1996 | CN1129400A Use of vitamin E. Tocopheryl derivatives in ophthalmic compositions |
08/21/1996 | CN1129137A Chinese ready-made medicine for external use for prevention and treatment of venereal disease |
08/21/1996 | CN1129135A Swelling-diminishing pain-relieving tincture |
08/21/1996 | CN1129132A Ulceromembrane of Chinese medicine and production technology thereof |
08/21/1996 | CN1129131A Medicinal powder for curing otitis media |
08/21/1996 | CN1129130A Medicament for treatment of cervical spondylopathy |
08/21/1996 | CN1129127A Liquid good for eyesight |
08/21/1996 | CN1129126A Tea of prolonging life |
08/21/1996 | CN1129124A Medicament for curing otitis |
08/21/1996 | CN1129121A Liniment for treatment of heperosteogeny |
08/21/1996 | CN1129119A Formular of Chinese medicinal capsul for auxiliary treatment of cancer and preparation method thereof |
08/21/1996 | CN1129114A Myogenic ointment of of removing toxic substances and preparation method thereof |
08/21/1996 | CN1129113A Agent with special effect for curing Acquired Immunity Deficiency Syndrome |
08/21/1996 | CN1129111A Ointment for treatment of silkworker's dermatitis |
08/21/1996 | CN1129110A Preparation method for lameness-relieving injection |
08/21/1996 | CN1129109A Medicine of alginic polysaccharide sulfate for treatment of nephrasthenia and angiopathy and preparation method thereof |
08/21/1996 | CN1129108A Oral liquor of gentamycin sulfate |
08/21/1996 | CN1129104A Total parenteral nutrition solution containing water-soluble vitamin B |
08/21/1996 | CN1129103A Nitrobenzoic pyridine preparation |
08/21/1996 | CN1129101A Compounded injection of ribonucleic acid and heparin |
08/21/1996 | CN1129100A Madumycin liquid agent |
08/21/1996 | CN1032571C Plaster for preventing and curing diarrhea and anorexia for infant and preparation method thereof |
08/20/1996 | US5548035 Biodegradable copolymer as drug delivery matrix comprising polyethyleneoxide and aliphatic polyester blocks |
08/20/1996 | US5547988 Topical application to reduce appearance of skin aging |
08/20/1996 | US5547985 Preventing toxic shock |
08/20/1996 | US5547959 For treatment of the autoimmune disease systemic lupus erythematosus |
08/20/1996 | US5547948 Controlled release of steroids from sugar coatings |
08/20/1996 | US5547943 Mixture with polyoxyethylene glycol; antiulcer agent |
08/20/1996 | US5547939 Broad spectrum antimicrobial compounds and methods of use |